These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31522179)

  • 1. Acquired Factor V Inhibitor with Hemorrhagic Symptoms after Prasugrel Hydrochloride Treatment.
    Sakatoku K; Takakuwa T; Miura A; Araki T; Fujitani Y; Yamamura R
    Acta Haematol; 2020; 143(5):478-480. PubMed ID: 31522179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Management of Acquired Factor V Inhibitor by Monitoring Factor V Activity, Antigen, and Inhibitor Values during Immunosuppressive Therapy.
    Mihara M; Ogawa Y; Nagasaka M; Kobayashi N; Shimizu H; Shinozawa K; Fukutake K; Inoue M; Murakami M; Handa H
    Acta Haematol; 2020; 143(5):486-490. PubMed ID: 31563916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].
    Shimizu I; Ichikawa N; Yotsumoto M; Sumi M; Ueno M; Kobayashi H
    Rinsho Ketsueki; 2008 Jun; 49(6):413-6. PubMed ID: 18646609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency.
    Ashizawa M; Kimura S; Wada H; Sakamoto K; Sato M; Terasako K; Kikuchi M; Nakasone H; Okuda S; Kako S; Yamazaki R; Oshima K; Matsuura K; Ohmori T; Madoiwa S; Nishida J; Mimuro J; Tabei K; Sakata Y; Kanda Y
    Hematology; 2013 Sep; 18(5):300-4. PubMed ID: 23683688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive role for recombinant activated factor VII in the treatment of bleeding secondary to a factor V inhibitor.
    William BM
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):327-8. PubMed ID: 18469559
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired factor V inhibitor: a nation-wide study of 38 patients.
    Goulenok T; Vasco C; Faille D; Ajzenberg N; De Raucourt E; Dupont A; Frere C; James C; Rabut E; Rugeri L; Schleinitz N; Sacré K; Papo T;
    Br J Haematol; 2021 Mar; 192(5):892-899. PubMed ID: 33471937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired Factor V Inhibitor with Symptoms and Titer of Inhibitor Differences: Report of Two Cases.
    Li F; Shu K; Liu J; Shen C; Wang X; Zhang Z; Jiang M
    Acta Haematol; 2019; 141(3):148-150. PubMed ID: 30783058
    [No Abstract]   [Full Text] [Related]  

  • 8. High Titer of Acquired Factor V Inhibitor Presenting with a Pseudo-deficiency of Multiple Coagulation Factors.
    Nakata K; Ueda S; Matsunaga H; Mima F; Ueda H; Yoshioka A; Kaneko S; Maruo K; Morris S; Yonemoto S; Hayashi D; Fujii N; Narahara H; Inui Y; Kawata S
    Intern Med; 2018 Feb; 57(3):393-397. PubMed ID: 29093398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recurrence of acquired factor V inhibitor after four years of remission].
    Akashi N; Ogawa Y; Yanagisawa K; Osaki Y; Shimizu H; Ishizaki T; Inoue M; Murakami M; Souri M; Ichinose A; Handa H
    Rinsho Ketsueki; 2019; 60(1):46-50. PubMed ID: 30726824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational Study.
    Räber L; Klingenberg R; Heg D; Kelbæk H; Roffi M; Tüller D; Baumbach A; Zanchin T; Carballo D; Ostojic M; Stefanini GG; Rodondi N; von Birgelen C; Moschovitis A; Engstrøm T; Gencer B; Auer R; Meier B; Mach F; Lüscher TF; Jüni P; Matter CM; Windecker S;
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1064-1074. PubMed ID: 26205445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A discrepancy between prothrombin time and Normotest (Hepaplastintest) results is useful for diagnosis of acquired factor V inhibitors.
    Kadohira Y; Yamada S; Hayashi T; Morishita E; Asakura H; Ichinose A
    Int J Hematol; 2018 Aug; 108(2):145-150. PubMed ID: 29611057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel--the European MULTIPRAC Registry.
    Clemmensen P; Grieco N; Ince H; Danchin N; Goedicke J; Ramos Y; Schmitt J; Goldstein P;
    Eur Heart J Acute Cardiovasc Care; 2015 Jun; 4(3):220-9. PubMed ID: 25182465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of asymptomatic acquired factor V inhibitor after the administration of antibiotics].
    Kinjo Y; Yoshimura K; Suzuki T; Shinozawa K; Nakasone K; Yoshimata T; Nishihira M; Henzan E
    Rinsho Ketsueki; 2014 Nov; 55(11):2311-5. PubMed ID: 25501413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acquired inhibitor against coagulation factor V with severe hematuria].
    Hasegawa M; Tanaka T; Kii T; Fujiwara S; Ikeda N; Kinntaka D; Takeuti T; Tanaka H; Ikemoto T
    Rinsho Ketsueki; 2003 Sep; 44(9):933-9. PubMed ID: 14577313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful management of a possible antibiotic-related acquired factor V inhibitor: a case report and review of the literature.
    Motwani P; Howard L; Ali SS
    Acta Haematol; 2013; 129(3):182-4. PubMed ID: 23257771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired Factor V Deficiency Associated with CFPM Administration.
    Yamanishi M; Nishimi Y; Usui M; Miki K; Imashuku S
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acquired factor V inhibitor].
    Yamada S; Asakura H
    Rinsho Ketsueki; 2020; 61(7):791-798. PubMed ID: 32759567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A very potent factor V inhibitor interferes with the levels of all coagulation factors and causes a fatal hemorrhagic syndrome.
    Hoffmann C; Amiral J; Rezig S; Kerspern H; Jantzem H; Robin S; Collins A; Mornet C; Mingant F; Pan Petesch B; Ianotto JC; Lippert E; Galinat H
    Eur J Haematol; 2019 Aug; 103(2):137-139. PubMed ID: 31102471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prasugrel hydrochloride for the treatment of acute coronary syndrome patients.
    Gunarathne A; Hussain S; Gershlick AH
    Expert Rev Cardiovasc Ther; 2016 Nov; 14(11):1215-1226. PubMed ID: 27701930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding associated with acquired factor V inhibitor in a patient on warfarin treated successfully with prednisolone.
    Khalafallah A; Grabek J; Hayes R; Mohamed M
    BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23921688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.